Goldman Sachs Group Inc Charles River Laboratories International, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 379,045 shares of CRL stock, worth $66.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
379,045
Previous 997,488
62.0%
Holding current value
$66.3 Million
Previous $150 Million
61.69%
% of portfolio
0.01%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding CRL
# of Institutions
619Shares Held
52.6MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.02 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$890 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$659 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$401 Million0.63% of portfolio
-
State Street Corp Boston, MA1.86MShares$325 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.9B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...